The Vice President, Head of Early Assets, serves as the strategic and scientific leader for Alnylam’s early‑stage medical programs across CNS, cardiovascular, and hematology indications. As a key member of the Medical Affairs Leadership Team (MALT), this leader holds primary accountability for defining and executing the global medical strategy for multiple early‑stage assets and shaping Alnylam’s future portfolio direction. The VP will influence enterprise‑level investment and development decisions, lead and develop a high‑performing team of medical directors, and partner closely with Program Leadership, Commercial, Clinical Development, Value & Evidence Strategy (VeST), and Patient Advocacy to ensure integrated, data‑driven, cross‑functional plans. This role is central to establishing early medical strategy, advancing evidence generation, and preparing markets for future launch success.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Education Level
Ph.D. or professional degree